US2009263868A1PendingUtilityA1

Nucleotide Compositions Comprising Photocleavable Markers And Methods Of Preparation Thereof

74
Assignee: AMBERGEN INCPriority: Jul 13, 2001Filed: Jun 16, 2009Published: Oct 22, 2009
Est. expiryJul 13, 2021(expired)· nominal 20-yr term from priority
A61K 49/0021C07H 19/04A61K 49/0032C07H 21/04C07H 21/02C07H 19/00A61K 49/0052
74
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Labelled nucleotides and polynucleotides useful in the sequencing of nucleic acids are described. Methods of preparing photocleavable marker nucleotides and photocleavable marker-polynucleotide conjugates are described. Such photocleavable marker nucleotides can be incorporated into nucleic acid so as to create photocleavable marker-polynucleotide conjugates.

Claims

exact text as granted — not AI-modified
1 . A conjugate, comprising a nucleotide attached to a fluorescent marker through a cleavable linker, said marker comprising BODIPY. 
   
   
       2 . The conjugate of  claim 1 , wherein said nucleotide is a ribonucleotide. 
   
   
       3 . The conjugate of  claim 1 , wherein said nucleotide is a deoxyribonucleotide. 
   
   
       4 . The conjugate of  claim 1 , wherein said cleavable linker is a photocleavable linker. 
   
   
       5 . A method, comprising:
 a) providing i) nucleic acid, ii) the conjugate of  claim 1 , and iii) a nucleic acid-modifying enzyme;   b) mixing said nucleic acid and said nucleic acid-modifying enzyme in the presence of said conjugate under conditions such that said conjugate is incorporated into said nucleic acid to produce labeled nucleic acid.   
   
   
       6 . The method of  claim 5 , wherein said nucleic acid is RNA. 
   
   
       7 . The method of  claim 5 , wherein said nucleic acid is DNA. 
   
   
       8 . The method of  claim 5 , wherein said nucleic acid-modifying enzyme is a polymerase. 
   
   
       9 . The method of  claim 5 , wherein said nucleic acid-modifying enzyme is a terminal transferase. 
   
   
       10 . The method of  claim 5 , wherein said nucleic acid-modifying enzyme is a ligase.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.